ViaDerma (ViaDerma) EBIT per Share : $27.41 (TTM As of Jun. 2012)

View and export this data going back to 2008. Start your Free Trial

What is ViaDerma EBIT per Share?

ViaDerma's EBIT per Share for the three months ended in Jun. 2012 was $11.12. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2012 was $27.41.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ViaDerma's EBIT per Share or its related term are showing as below:

VDRM's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.4
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

ViaDerma's EBIT for the three months ended in Jun. 2012 was $1.52 Mil.

ViaDerma EBIT per Share Historical Data

The historical data trend for ViaDerma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma EBIT per Share Chart

ViaDerma Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

EBIT per Share

-12.82

67.77

46.34

56.69

29.56

ViaDerma Quarterly Data
	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12
EBIT per Share	Get a 7-Day Free Trial															9.85	5.07	5.90	5.32	11.12

ViaDerma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ViaDerma's EBIT per Share for the fiscal year that ended in Dec. 2011 is calculated as

	EBIT per Share		(A: Dec. 2011 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	4.049	/	0.137
=	29.55

ViaDerma's EBIT per Share for the quarter that ended in Jun. 2012 is calculated as

	EBIT per Share		(Q: Jun. 2012 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	1.523	/	0.137
=	11.12

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $27.41

ViaDerma (OTCPK:VDRM) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ViaDerma EBIT per Share Related Terms

Thank you for viewing the detailed overview of ViaDerma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ViaDerma (ViaDerma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292

Website

https://www.viaderma.com

ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.